Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded on a mission to discover, develop and commercialize innovative, first-in-class medicines that address significant unmet medical needs, today announced it will hold a conference call on Thursday, October 30, 2025 at 4:30 PM Eastern Time to discuss financial results and provide a third quarter business update from […]
Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded on the mission to discover, develop and commercialize innovative, first-in-class medicines that address significant unmet medical needs, today announced the appointment of Sue Hohenleitner as Chief Financial Officer (CFO), effective November 4, 2025. Ms. Hohenleitner is a proven financial leader, with more than 30 years of experience […]
PyroGenesis Inc. (“PyroGenesis” or “the Company”) (TSX: PYR,OTC:PYRGF) (OTCQX: PYRGF) (FRA: 8PY1), the leader in innovation for ultra-high temperature processes and engineering, and a technology provider for heavy industry and defense, provides the following comment regarding a recent online post by a current member of the Board of management of the company. On Saturday, October […]
Marimaca Copper Corp. (TSX: MARI,OTC:MARIF) (ASX: MC2) (“Marimaca” or the “Company”) announces that it has submitted the technical report of the feasibility study for the Marimaca Oxide Deposit Project in the Antofagasta Region, Chile (the “Report”). The report was prepared in accordance with National Instrument 43-101 standards for mineral project disclosure. The report supports the […]
Benton Resources Inc. (TSXV: BEX,OTC:BNTRF) (“Benton” or the “Company”) is pleased to announce that the newly announced Clean Air Metals PEA delivers a pre-tax net present value of C$219.4 million, 39% IRR, for the Thunder Bay North Project. See Clean Air Metals (TSXV: AIR) Press Release Date October 9, 2025. Benton currently owns 24.6 million […]
(The Newswire) Vancouver, British Columbia, October 8, 2025 TheNewswire – Avrupa Minerals Ltd. (TSX-V: AVU) is pleased to announce that it has acquired more exploration area in the prolific Vihanti-Pyhäsalmi VMS district of Central Finland through its Finland-based partnership, Akkerman Finland Oy (AFOy). AFOy expanded its holdings in the district with a new exploration area […]
Astria Therapeutics, Inc. (NASDAQ:ATXS), a biopharmaceutical company focused on developing life-changing therapies for allergic and immunological diseases, today announced the initiation of the Phase 3 ORBIT-EXPANSE long-term study of navenibart in people with hereditary angioedema (HAE). “The initiation of ORBIT-EXPANSE marks exciting progress in the development of navenibart,” said Christopher Morabito, MD, Chief Medical Officer […]